Literature DB >> 20057314

Redefining outcome measures in schizophrenia: integrating social and clinical parameters.

Amresh Shrivastava1, Megan Johnston, Nilesh Shah, Yves Bureau.   

Abstract

PURPOSE OF REVIEW: Schizophrenia is a complex neurobehavioral disorder for which there are many promising new treatments. There is, however, a discrepancy in outcome measure reports when they are obtained from patients, relatives, caregivers, or professionals, making it difficult to determine the level of recovery. This lack of agreement may result from limitations of the measurement tools themselves, which are not comprehensive and may be measuring different aspects of outcome. Alternatively, it could be that the conceptual understanding of outcome and recovery require development. RECENT
FINDINGS: For various reasons, patients assessed as 'recovered' remain excluded from mainstream society. We are of the opinion that present outcome measures do not capture real-life situations. We propose that the concept of recovery be carefully defined and the gold standard of outcome should incorporate social and clinical parameters. We attempt to redefine recovery. Patients who have shown clinical improvement do not necessarily do well in everyday situations even though there is obvious clinical improvement. Therefore, it has been repeatedly argued that a consensus of recovery should be determined and that routine clinical practice should then adapt to the agreed criteria.
SUMMARY: We argue that the outcome measures should be multidimensional and consist of at least two parameters: clinical remission and social outcome.

Entities:  

Mesh:

Year:  2010        PMID: 20057314     DOI: 10.1097/YCO.0b013e328336662e

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  13 in total

1.  Quality of life and illness beliefs in individuals with early psychosis.

Authors:  Kate Theodore; Sonia Johnson; Anna Chalmers-Brown; Rhianne Doherty; Chris Harrop; Lyn Ellett
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-03-04       Impact factor: 4.328

Review 2.  A systematic review and meta-analysis of recovery in schizophrenia.

Authors:  Erika Jääskeläinen; Pauliina Juola; Noora Hirvonen; John J McGrath; Sukanta Saha; Matti Isohanni; Juha Veijola; Jouko Miettunen
Journal:  Schizophr Bull       Date:  2012-11-20       Impact factor: 9.306

3.  Measuring the later stages of the recovery journey: insights gained from clubhouse members.

Authors:  Nicola Hancock; Anita Bundy; Anne Honey; Stephanie Helich; Sally Tamsett
Journal:  Community Ment Health J       Date:  2012-07-24

Review 4.  Neurocognition: clinical and functional outcomes in schizophrenia.

Authors:  Martin Lepage; Michael Bodnar; Christopher R Bowie
Journal:  Can J Psychiatry       Date:  2014-01       Impact factor: 4.356

5.  Dorsolateral prefrontal lobe volume and neurological soft signs as predictors of clinical social and functional outcome in schizophrenia: A longitudinal study.

Authors:  Rishikesh V Behere
Journal:  Indian J Psychiatry       Date:  2013-04       Impact factor: 1.759

6.  Predicting functional remission in patients with schizophrenia: a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome.

Authors:  Marcelo Valencia; Ana Fresán; Yoram Barak; Francisco Juárez; Raul Escamilla; Ricardo Saracco
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-10       Impact factor: 2.570

Review 7.  Age at onset and the outcomes of schizophrenia: A systematic review and meta-analysis.

Authors:  Johanna Immonen; Erika Jääskeläinen; Hanna Korpela; Jouko Miettunen
Journal:  Early Interv Psychiatry       Date:  2017-04-27       Impact factor: 2.732

8.  Long-Term Antipsychotic Effectiveness in First Episode of Psychosis: A 3-Year Follow-Up Randomized Clinical Trial Comparing Aripiprazole, Quetiapine, and Ziprasidone.

Authors:  Marcos Gómez-Revuelta; José María Pelayo-Terán; María Juncal-Ruiz; Víctor Ortiz-García de la Foz; Javier Vázquez-Bourgon; Ana González-Pinto; Benedicto Crespo-Facorro
Journal:  Int J Neuropsychopharmacol       Date:  2018-12-01       Impact factor: 5.176

9.  The effect of aripiprazole once-monthly on personal and social functioning: post hoc analyses of acute and long-term studies.

Authors:  Timothy Peters-Strickland; Ross A Baker; Pedro Such; Peter Zhang; Jessica J Madera
Journal:  Neuropsychiatr Dis Treat       Date:  2019-06-24       Impact factor: 2.570

10.  Atypical antipsychotics usage in long-term follow-up of first episode schizophrenia.

Authors:  Amresh Shrivastava; Megan Johnston; Kristen Terpstra; Larry Stitt; Nilesh Shah
Journal:  Indian J Psychiatry       Date:  2012-07       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.